Here, we detected positive CD52 expression in tumors from TNBC patients and demonstrated that CD52 on TNBC cells facilitates immune evasion by engaging the inhibitory receptor sialic acid-binding Ig-like lectin G (Siglec-G) on tumor-associated macrophages. The gene discussed is CD52; the disease is neoplasm.